Replies to post #4180 on Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

Just in case someone is not paying attention to the other board:

From bbmichael2000:
"Re: Went to Damaj lecture last night in Baltimore...
Dr. Damaj did discuss a newer room temperature Vitaros which could possibly be an OTC product. The shelf life is 3 years versus 2 for the Warner chilcott version. FDA is up to Warner Chilcott which bought the rights to version 1 of Vitaros. From what Dr. Damaj said, Warner Chilcott had no interest in seeking FDA approval but then when approval came in Canada, that is when they realized what they were sitting on and have started the process. There are no delays in Europe or issues - approval usually goes easier than in Canada - so no one forsees a problem."

And you are right, Markkind, BB handled the abuse well.

I should add that Apricus cannot market the room temp version in the US without negotiating with Warner...per my previous discussions with IR. I had hoped otherwise.